Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2023-03-17

Clinical Trial Update: Eplerenone as a Supplement to Epidural Steroid Injections [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating eplerenone as a supplement to epidural steroid injections was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • eplerenone (eplerenone)

Snippet

Sponsor: University of Cincinnati | Conditions: Degenerative Intervertebral Discs, Sciatic Radiculopathy | Phase 4 | Status: WITHDRAWN